MSD Congratulates Senegal on the Successful Launch of its National Immunisation Programme for Human-Papillomavirus (HPV)

MSD ([www.MSD.co.za](http://www.msd.co.za/)), known as Merck & Co., Inc., (NYSE: MRK) in the United States and Canada, congratulates Senegal on the successful launch of the National Immunisation Programme (NIP) for the Human-Papillomavirus (HPV – the main cause of cervical cancer).[1] Approximately 530 000 women are diagnosed with cervical cancer around the world each year.[2] In Sub-Saharan […]

MSD ([www.MSD.co.za](http://www.msd.co.za/)), k...

Source : http://feedproxy.google.com/~r/Appa-sourceTheAfric...